Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184987 | PMC |
| http://dx.doi.org/10.1016/j.metabol.2020.154251 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Building a Culture of Health Through Leader-Inspired Nutrition.
Mil Med
January 2025
Consortium for Health and Military Performance, Department of Military and Emergency Medicine, F. Edward Hébert School of Medicine, Uniformed Services University, Bethesda, MD 20814, USA.
The balance of operational readiness and maintaining a healthy recruitment force presents increasing challenges within the DoD. Chronic preventable diseases, such as overweight and obesity, along with musculoskeletal injuries, are threats to recruitment and retention. Novel approaches are needed and leaders are in a unique position to serve a key role in influencing nutrition readiness.
View Article and Find Full Text PDFCommentary: Teens, screens, and sleep: the important role of screen time in the pathway between adolescent insomnia and obesity.
J Pediatr Psychol
January 2025
Department of Psychology, Syracuse University, Syracuse, NY, United States.
Hunting for heroes: Brain neurons mediating GLP-1R agonists in obesity treatment.
Obes Med
December 2024
The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, MD Anderson Cancer Center & UTHealth Houston Graduate School for Biomedical Sciences, University of Texas Health Science at Houston, Texas, 77030, USA.
Glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1RAs) have proven to be highly effective in reducing obesity across species and ages, gaining unmet popularity in clinical treatments against obesity. Although extensive research efforts have been made to explore how the brain regulates body weight homeostasis including the effect brought up by GLP-1 and its synthetic analogs GLP-1RAs, the identity of neurons and neural pathways that are responsible for the observed anti-obesity effect of GLP-1RAs remain largely elusive. Excitingly, three recent high-profile studies presented compelling evidence that each argues for the importance of GLP-1Rs in the dorsomedial hypothalamus, hindbrain, or lateral septum, respectively, in mediating the anti-obesity effect of GLP-1RAs.
View Article and Find Full Text PDFSpotlight commentary: Changes in pharmacokinetics following significant weight loss.
Br J Clin Pharmacol
January 2025
College of Pharmacy, Qatar University, Doha, Qatar.
Redefining glomerular hyperfiltration: pathophysiology, clinical implications, and novel perspectives.
Hypertens Res
January 2025
Department of Nephrology and Hypertension, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!